Behavioral and endocrine effects of growth hormone administration in aged female rats
Growth hormone (GH) secretion declines during normal aging along with reproductive activity in mammalian species. Various behavioral changes also occur in aged animals. In these experiments we have studied the effects of GH administration on behavioral and endocrine alterations exhibited by aged (18 months old) female rats of the Sprague-Dawley strain. Animals were selected showing at least 2 weeks of cornified vaginal smears (constant estrous) and treated with GH (0.1 mg/kg SC) daily for 8 weeks. Vaginal smears performed during the drug treatment revealed a recovery of estrous cycle in 60% of animals. GH treatment was also followed by an increased acquisition of shuttle-box active avoidance behavior and a facilitated retention of passive avoidance response. Compared to saline-injected controls, female rats treated with GH also exhibited a decrease of novelty-induced excessive grooming. The endocrine pattern of GH-treated aged female rats revealed a decrease in plasma prolactin levels and an increase in luteinizing hormone and 17 beta-estradiol levels as compared to those of control animals. These results support the concept that behavioral and endocrine alterations occurring in aging are not irreversible and that GH may interfere with these changes probably by means of its trophic action on different target organs.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1996 |
---|---|
Erschienen: |
1996 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Psychoneuroendocrinology - 21(1996), 4 vom: 26. Mai, Seite 401-10 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Drago, F [VerfasserIn] |
---|
Themen: |
4TI98Z838E |
---|
Anmerkungen: |
Date Completed 03.01.1997 Date Revised 14.09.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM088137953 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM088137953 | ||
003 | DE-627 | ||
005 | 20231222073234.0 | ||
007 | tu | ||
008 | 231222s1996 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0294.xml |
035 | |a (DE-627)NLM088137953 | ||
035 | |a (NLM)8844878 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Drago, F |e verfasserin |4 aut | |
245 | 1 | 0 | |a Behavioral and endocrine effects of growth hormone administration in aged female rats |
264 | 1 | |c 1996 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 03.01.1997 | ||
500 | |a Date Revised 14.09.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Growth hormone (GH) secretion declines during normal aging along with reproductive activity in mammalian species. Various behavioral changes also occur in aged animals. In these experiments we have studied the effects of GH administration on behavioral and endocrine alterations exhibited by aged (18 months old) female rats of the Sprague-Dawley strain. Animals were selected showing at least 2 weeks of cornified vaginal smears (constant estrous) and treated with GH (0.1 mg/kg SC) daily for 8 weeks. Vaginal smears performed during the drug treatment revealed a recovery of estrous cycle in 60% of animals. GH treatment was also followed by an increased acquisition of shuttle-box active avoidance behavior and a facilitated retention of passive avoidance response. Compared to saline-injected controls, female rats treated with GH also exhibited a decrease of novelty-induced excessive grooming. The endocrine pattern of GH-treated aged female rats revealed a decrease in plasma prolactin levels and an increase in luteinizing hormone and 17 beta-estradiol levels as compared to those of control animals. These results support the concept that behavioral and endocrine alterations occurring in aging are not irreversible and that GH may interfere with these changes probably by means of its trophic action on different target organs | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Estradiol |2 NLM | |
650 | 7 | |a 4TI98Z838E |2 NLM | |
650 | 7 | |a Prolactin |2 NLM | |
650 | 7 | |a 9002-62-4 |2 NLM | |
650 | 7 | |a Luteinizing Hormone |2 NLM | |
650 | 7 | |a 9002-67-9 |2 NLM | |
650 | 7 | |a Growth Hormone |2 NLM | |
650 | 7 | |a 9002-72-6 |2 NLM | |
700 | 1 | |a Di Leo, F |e verfasserin |4 aut | |
700 | 1 | |a Ikonomou, S |e verfasserin |4 aut | |
700 | 1 | |a Anzallo, C |e verfasserin |4 aut | |
700 | 1 | |a Busà, L |e verfasserin |4 aut | |
700 | 1 | |a LoPresti, L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Psychoneuroendocrinology |d 1993 |g 21(1996), 4 vom: 26. Mai, Seite 401-10 |w (DE-627)NLM000122548 |x 1873-3360 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:1996 |g number:4 |g day:26 |g month:05 |g pages:401-10 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 1996 |e 4 |b 26 |c 05 |h 401-10 |